This Eaton Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga·12/09 14:06
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
RBC Capital analyst Nik Modi upgraded Colgate-Palmolive Company(NYSE:CL) from Sector Perform to Outperform and announced a price target of $88. Colgate-Palmolive shares closed at $76.11 on Monday. See how other analysts view this stock.
Wolfe Research analyst Nigel Coe upgraded Eaton Corporation plc(NYSE:ETN) from Peer Perform to Outperform and announced a $413 price target. Eaton shares closed at $343.39 on Monday. See how other analysts view this stock.
HC Wainwright & Co. analyst Mitchell S. Kapoor upgraded Lyell Immunopharma, Inc. (NASDAQ:LYEL) from Neutral to Buy and raised the price target from $20 to $45. Lyell Immunopharma shares closed at $28.36 on Monday. See how other analysts view this stock.
RBC Capital analyst Arun Viswanathan upgraded RPM International Inc. (NYSE:RPM) from Sector Perform to Outperform and boosted the price target from $121 to $132. RPM shares closed at $102.63 on Monday. See how other analysts view this stock.
Rosenblatt analyst Blair Abernethy upgraded Synopsys, Inc. (NASDAQ:SNPS) from Neutral to Buy and lowered the price target from $605 to $560. Synopsys shares closed at $465.75 on Friday. See how other analysts view this stock.
Considering buying ETN stock? Here’s what analysts think:
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.